Duality Advisers’s Integra LifeSciences IART Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-59,916
Closed -$2.12M 250
2024
Q1
$2.12M Buy
59,916
+30,484
+104% +$1.22M 0.21% 173
2023
Q4
$1.28M Buy
29,432
+7,252
+33% +$285K 0.14% 264
2023
Q3
$847K Sell
22,180
-18,634
-46% -$784K 0.1% 324
2023
Q2
$1.68M Buy
+40,814
New +$1.96M 0.21% 189
2022
Q4
Sell
-36,123
Closed -$1.53M 670
2022
Q3
$1.53M Buy
36,123
+25,912
+254% +$1.33M 0.17% 236
2022
Q2
$552K Buy
10,211
+2,330
+30% +$140K 0.05% 447
2022
Q1
$506K Sell
7,881
-3,489
-31% -$230K 0.05% 468
2021
Q4
$762K Sell
11,370
-19,366
-63% -$1.31M 0.08% 340
2021
Q3
$2.1M Buy
30,736
+17,582
+134% +$1.24M 0.16% 238
2021
Q2
$898K Buy
+13,154
New +$930K 0.08% 348
2020
Q4
Sell
-28,200
Closed -$1.33M 631
2020
Q3
$1.33M Buy
28,200
+19,745
+234% +$939K 0.09% 304
2020
Q2
$397K Buy
+8,455
New +$416K 0.04% 328
2020
Q1
Sell
-11,584
Closed -$675K 155
2019
Q4
$675K Sell
11,584
-266
-2% -$15.8K 0.04% 312
2019
Q3
$712K Buy
+11,850
New +$706K 0.04% 273

Other funds holding IART

Duality Advisers's IART Position: Q2 2024 in Review

Duality Advisers sold out of Integra LifeSciences (IART) in Q2 2024, closing a stake of 59,916 shares — an estimated $2.12M sold.

Duality Advisers first reported a position in IART in Q3 2019 and held it in 14 quarters. The position peaked at $2.12M in Q1 2024. 238 funds tracked by Wall St. Rank hold IART as of Q2 2024.

  • Duality Advisers reported no remaining Integra LifeSciences position as of Q2 2024 after selling out during the quarter.
  • Duality Advisers sold 59,916 Integra LifeSciences shares in Q2 2024, an estimated $2.12M.
  • Duality Advisers first reported a position in Integra LifeSciences in Q3 2019 and held it in 14 quarters.
  • Duality Advisers's Integra LifeSciences position peaked at $2.12M in Q1 2024.
  • 238 funds tracked by Wall St. Rank held Integra LifeSciences as of Q2 2024.

Based on Duality Advisers's 13F filing for Q2 2024.